Core Alternative Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-8
Closed -$3.41K – 274
2025
Q3
$3.41K Hold
8
– – ﹤0.01% 213
2025
Q2
$3.06K Hold
8
– – ﹤0.01% 213
2025
Q1
$2.76K Sell
8
-76
-90% -$24.4K ﹤0.01% 210
2024
Q4
$25.2K Hold
84
– – 0.01% 182
2024
Q3
$34.1K Hold
84
– – 0.01% 165
2024
Q2
$27K Hold
84
– – 0.01% 177
2024
Q1
$28K Sell
84
-37
-31% -$11.3K 0.01% 170
2023
Q4
$32.8K Sell
121
-13
-10% -$3.21K 0.01% 192
2023
Q3
$33K Hold
134
– – 0.01% 208
2023
Q2
$40.7K Buy
134
+4
+3% +$1.11K 0.01% 164
2023
Q1
$34.3K Buy
130
+13
+11% +$3.3K ﹤0.01% 183
2022
Q4
$28.1K Buy
117
+3
+3% +$672 ﹤0.01% 196
2022
Q3
$21K Buy
114
+8
+8% +$1.59K ﹤0.01% 215
2022
Q2
$18K Buy
106
+19
+22% +$4.08K ﹤0.01% 229
2022
Q1
$22K Buy
87
+75
+625% +$18.8K 0.01% 208
2021
Q4
$3K Buy
+12
New +$2.94K ﹤0.01% 241

Other funds holding HCA

Core Alternative Capital's HCA Position: Q4 2025 in Review

Core Alternative Capital sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 8 shares — an estimated $3.41K sold.

Core Alternative Capital first reported a position in HCA in Q4 2021 and held it in 16 quarters. The position peaked at $40.7K in Q2 2023. 1,399 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

  • Core Alternative Capital reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
  • Core Alternative Capital sold 8 HCA Healthcare shares in Q4 2025, an estimated $3.41K.
  • Core Alternative Capital first reported a position in HCA Healthcare in Q4 2021 and held it in 16 quarters.
  • Core Alternative Capital's HCA Healthcare position peaked at $40.7K in Q2 2023.
  • 1,399 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.